SLC6 Transporter Folding Diseases and Pharmacochaperoning
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
The human genome encodes 19 genes of the solute carrier 6 (SLC6) family; non-synonymous changes in the coding sequence give rise to mutated transporters, which are misfolded and thus cause diseases in the affected individuals. Prominent examples include mutations in the transporters for dopamine (DAT, SLC6A3), for creatine (CT1, SLC6A8), and for glycine (GlyT2, SLC6A5), which result in infantile dystonia, mental retardation, and hyperekplexia, respectively. Thus, there is an obvious unmet medical need to identify compounds, which can remedy the folding deficit. The pharmacological correction of folding defects was originally explored in mutants of the serotonin transporter (SERT, SLC6A4), which were created to study the COPII-dependent export from the endoplasmic reticulum. This led to the serendipitous discovery of the pharmacochaperoning action of ibogaine. Ibogaine and its metabolite noribogaine also rescue several disease-relevant mutants of DAT. Because the pharmacology of DAT and SERT is exceptionally rich, it is not surprising that additional compounds have been identified, which rescue folding-deficient mutants. These compounds are not only of interest for restoring DAT function in the affected children. They are also likely to serve as useful tools to interrogate the folding trajectory of the transporter. This is likely to initiate a virtuous cycle: if the principles underlying folding of SLC6 transporters are understood, the design of pharmacochaperones ought to be facilitated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low brain creatine content has been associated with muscle myopathies (e.g., weakness), voluntary or involuntary movement disorders that can affect muscle function and coordination, speech development, epilepsy, cognitive and motor development delays, and/or autism [53,61,203,204,206,207,208,209,210].”
From Creatine in health and disease (2021) · cites this paper as [204]
In the citing paper
“For this reason, high-dose, long-term creatine supplementation (e.g., 0.3–0.8 g/kg/day) throughout the lifespan is a nutritional strategy of increasing brain creatine content in these populations [53,61,203,204,206,207,208,209,210,211,212,213,214].”
From Creatine in health and disease (2021) · cites this paper as [204]
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
Statistical potential for assessment and prediction of protein structures
Shen, M., & Sali, A. (2006) · Protein Science · doi:10.1110/ps.062416606 · Cited by 2,307
The Protein-Folding Problem, 50 Years On
Dill, K. A., & MacCallum, J. L. (2012) · Science · doi:10.1126/science.1219021 · Cited by 1,699
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
X-ray structures and mechanism of the human serotonin transporter
Coleman, J. A., Green, E. M., & Gouaux, E. (2016) · Nature · doi:10.1038/nature17629 · Cited by 668
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Penmatsa, A., Wang, K. H., & Gouaux, E. (2013) · Nature · doi:10.1038/nature12533 · Cited by 612
Dopamine Is a Regulator of Arousal in the Fruit Fly
Kume, K., Kume, S., Park, S. K., Hirsh, J., & Jackson, F. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2048-05.2005 · Cited by 597
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594
Enhanced tonic GABAA inhibition in typical absence epilepsy
Cope, D. W., Di Giovanni, G., Fyson, S. J., Orbán, G., Errington, A. C., Lőrincz, M. L., Gould, T. M., Carter, D. A., & Crunelli, V. (2009) · Nature Medicine · doi:10.1038/nm.2058 · Cited by 431
Research works printed but not linked: 1
- Levinthal C (1969) How to fold graciously. In: DeBrunner JTP, Munck E (eds) Mössbauer spectroscopy in biological systems. University of Illinois Press, Allerton House, Monticello, IL, pp 22–24
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Kasture, A. S., Hummel, T., Sučić, S., & Freissmuth, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061788 · Cited by 108
Self-citationA systematic literature review of clinical trials and therapeutic applications of ibogaine
Köck, P., Froelich, K., Walter, M., Lang, U. E., & Dürsteler, K. M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108717 · Cited by 88
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome
Farr, C. V., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588954 · Cited by 58
Self-citationEl‐Kasaby, A., Kasture, A. S., Koban, F., Hoťka, M., Asjad, H. M. M., Kubista, H., Freissmuth, M., & Sučić, S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.015 · Cited by 58
Self-citationBhat, S., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107785 · Cited by 55
Self-citationRodríguez, P. M., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., Sameš, D., Scorza, C., & Carrera, I. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00152 · Cited by 48
Fischer, F. P., Kasture, A. S., Hummel, T., & Sučić, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.834498 · Cited by 45
Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters
Bhat, S., Guthrie, D. A., Kasture, A. S., El‐Kasaby, A., Cao, J., Bonifazi, A., Ku, T. C., Giancola, J. B., Hummel, T., Freissmuth, M., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00102 · Cited by 37
Self-citationA comparative review on the well-studied GAT1 and the understudied BGT-1 in the brain
Bhatt, M., Gauthier-Manuel, L., Lazzarin, E., Zerlotti, R., Ziegler, C. M., Bazzone, A., Stockner, T., & Bossi, E. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1145973 · Cited by 36
Self-citationBhat, S., Newman, A. H., & Freissmuth, M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180512 · Cited by 34
Self-citationInvestigating the Mechanism of Sodium Binding to SERT Using Direct Simulations
Szöllősi, D., & Stockner, T. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673782 · Cited by 29
Self-citationKasture, A. S., Fischer, F. P., Kunert, L., Burger, M., Burgstaller, A. C., El‐Kasaby, A., Hummel, T., & Sučić, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1074427 · Cited by 25
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants
Silva, D. B., Trinidad, M. I., Ljungdahl, A., Revalde, J. L., Berguig, G. Y., Wallace, W., Patrick, C. S., Bomba, L., Arkin, M. R., Dong, S., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.04.021 · Cited by 24
Distinct contribution of axonal and somatodendritic serotonin transporters in drosophila olfaction
Kasture, A. S., Bartel, D., Steinkellner, T., Sučić, S., Hummel, T., & Freissmuth, M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.007 · Cited by 23
Self-citationHyperekplexia-associated mutations in the neuronal glycine transporter 2
López‐Corcuera, B., Arribas-González, E., & Aragón, C. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.014 · Cited by 22
Sodium Binding Stabilizes the Outward-Open State of SERT by Limiting Bundle Domain Motions
Szöllősi, D., & Stockner, T. (2022) · Cells · doi:10.3390/cells11020255 · Cited by 20
Self-citationProteostasis network deregulation signatures as biomarkers for pharmacological disease intervention
Brehme, M., Sverchkova, A., & Voisine, C. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.03.008 · Cited by 17
El‐Kasaby, A., Boytsov, D., Kasture, A. S., Krumpl, G., Hummel, T., Freissmuth, M., & Sandtner, W. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000881 · Cited by 15
Self-citationExtracellular loops of the serotonin transporter act as a selectivity filter for drug binding
Esendir, E., Burtscher, V., Coleman, J. A., Zhu, R., Gouaux, E., Freissmuth, M., & Sandtner, W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100863 · Cited by 14
Self-citationA mechanism of uncompetitive inhibition of the serotonin transporter
Bhat, S., El‐Kasaby, A., Kasture, A. S., Boytsov, D., Reichelt, J. B., Hummel, T., Sučić, S., Pifl, C., Freissmuth, M., & Sandtner, W. (2023) · eLife · doi:10.7554/elife.82641 · Cited by 13
Self-citationGechijian, L., Muncipinto, G., Rettenmaier, T. J., Labenski, M., Rusu, V., Rosskamp, L., Conway, L., van Kalken, D., Gross, L., Iantosca, G., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00571 · Cited by 12
Ponleitner, M., Szöllősi, D., El‐Kasaby, A., Koban, F., Freissmuth, M., & Stockner, T. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000413 · Cited by 11
Self-citationShah, N., Kovalchuk, V., Zerlotti, R., Cole, K., Bazzone, A., Sitte, H. H., Hummel, T., Kasture, A. S., & Sučić, S. (2025) · The FASEB Journal · doi:10.1096/fj.202403159rr · Cited by 10
Clarke, A., Farr, C. V., El‐Kasaby, A., Szöllősi, D., Freissmuth, M., Sučić, S., & Stockner, T. (2023) · Protein Science · doi:10.1002/pro.4842 · Cited by 9
Self-citationRescue of Misfolded Organic Cation Transporter 3 Variants
Angenoorth, T. J. F., Maier, J., Stankovic, S., Bhat, S., Sučić, S., Freissmuth, M., Sitte, H. H., & Yang, J. (2022) · Cells · doi:10.3390/cells12010039 · Cited by 8
Self-citationAsjad, H. M. M., Nasrollahi-Shirazi, S., Sučić, S., Freissmuth, M., & Nanoff, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112416 · Cited by 8
Self-citationStructural basis of vilazodone dual binding mode to the serotonin transporter
Kalenderoglou, I. E., Nygaard, A., Vogt, C. D., Turaev, A., Pape, T., Adams, N. B. P., Newman, A. H., & Loland, C. J. (2025) · Nature Communications · doi:10.1038/s41467-025-65202-3 · Cited by 5
de la Rocha‐Muñoz, A., Melgarejo, E., Aragón, C., & López‐Corcuera, B. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108543 · Cited by 5
Støier, J. F., Jørgensen, T. N., Sparsø, T., Rasmussen, H. B., Kumar, V., Newman, A. H., Blakely, R., Werge, T. M., Gether, U., & Herborg, F. (2023) · medRxiv · doi:10.1101/2023.08.29.23294386 · Cited by 5
Role of palmitoylation on the neuronal glycine transporter GlyT2
Felipe, R., Sarmiento-Jiménez, J., Camafeita, E., Vázquez, J., & López‐Corcuera, B. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16181 · Cited by 4
Farr, C. V., Xiao, Y., El‐Kasaby, A., Schupp, M., Hoťka, M., Mauro, G. D., Clarke, A., Fernandez, M. P., Sandtner, W., Stockner, T., et al. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000995 · Cited by 4
Self-citationA New GlyT2 Variant Associated with Hyperekplexia
Sarmiento-Jiménez, J., Felipe, R., Núñez, E., Ferrando-Muñoz, A., Benito-Muñoz, C., Gago, F., Vázquez, J., Camafeita, E., Clement, E. M., Wilson, B. T., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146753 · Cited by 4
Reconstitution of GABA, Glycine and Glutamate Transporters
Danbolt, N. C., López‐Corcuera, B., & Zhou, Y. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03331-z · Cited by 4
Hamali, B., Pichler, S., Wischnitzki, E., Schicker, K. W., Burger, M., Holy, M., Jäntsch, K., Molin, M., Sehr, E. M., Kudlacek, O., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006428 · Cited by 4
Self-citationCrystallographic Characterization of Sodium Ions in a Bacterial Leucine/Sodium Symporter
Karasawa, A., Liu, H., Quick, M., Hendrickson, W. A., & Liu, Q. (2023) · Crystals · doi:10.3390/cryst13020183 · Cited by 2
Russo, E. E., Rezayof, A., Wallace, C. W., Williams, E. Q., Beerepoot, P., Milenkovic, M., Novalen, M., Blundell, A., Lipina, T. V., Locke, J. L., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00381-0 · Cited by 1
Author response: A mechanism of uncompetitive inhibition of the serotonin transporter
Bhat, S., El‐Kasaby, A., Kasture, A. S., Boytsov, D., Reichelt, J. B., Hummel, T., Sučić, S., Pifl, C., Freissmuth, M., & Sandtner, W. (2022) · eLife · doi:10.7554/elife.82641.sa2
Self-citationde la Rocha‐Muñoz, A. (2020) · Hispana
Połosak, K., & Połosak, K. (2024) · RCIN (Digital Repository of the Scientifics Institutes) (Institute of Archaeology and Ethnology of the Polish Academy of Sciences)
Protocol for stable cell line production to express muscle-type nicotinic receptor
Li, A., Sauer, D. B., & Dong, Y. Y. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104427
Development of diversified HTS cell-based assays for solute carrier drug discovery
Sassone, F., Koch, J., Batoulis, H., Tremolada, S., Ricci, F., Maresca, G., Ehrmann, A., & Scarabottolo, L. (2026) · SLAS DISCOVERY · doi:10.1016/j.slasd.2026.100333
Kasture, A. S., Fischer, F. P., Kunert, L., Burger, M. L., Burgstaller, A. C., El-Kasaby, A., Hummel, T., & Sucic, S. (2023) · doi:10.3389/fnins.2022.1074427.s001
Self-citation
Metadata
- Authors
- Freissmuth, M., Stockner, T., & Sucic, S.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Freissmuth, Michael
- Venue
- Handbook of experimental pharmacology
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 245
- Pages
- 249-270
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2765579156
- Cited by
- 42
- References
- 90
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1
- FWCI
- 4.08
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- pharmacochaperone, protein folding defects, dopamine transporter, serotonin transporter, creatine transporter, glycine transporter, ibogaine, noribogaine, hyperekplexia, intellectual disability, endoplasmic reticulum
- MeSH terms
- Solute Carrier Proteins, Animals, Humans, Mutation, Protein Folding, Molecular Chaperones, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Drug Discovery, Proteostasis Deficiencies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.